Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
43
43 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- ZasocitinibTAK- 279, NDI-034858Phase 317 trials
Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease
- AfimkibartRO7790121, RVT-3101Phase 312 trials
Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis
- MK-7240PRA023, TulisokibartPhase 310 trials
Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease
- LutikizumabABT-981Phase 38 trials
AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis
- DuvakitugSAR447189, TEV-48574 APhase 36 trials
Sanofi · Ulcerative Colitis, Crohn's Disease, Hidradenitis
- FilgotinibGS-6034, GLPG0634Phase 36 trials
Alfasigma S.p.A. · Ulcerative Colitis, Polyarticular Course Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis (JIA)
- ABX464ObefazimodPhase 35 trials
Abivax S.A. · Ulcerative Colitis, Moderately to Severely Active Crohn Disease
- Hemay005Mufemilast, Phosphodiesterase 4 inhibitorsPhase 34 trials
Ganzhou Hemay Pharmaceutical Co., Ltd · Moderate to Severe Ulcerative Colitis, Ulcerative Colitis (UC), COPD (Chronic Obstructive Pulmonary Disease)
- JNJ-78934804JNJ-4804Phase 34 trials
Johnson & Johnson (Janssen) · Colitis, Ulcerative, Crohn's Disease, Crohn Disease
- brivekimigSAR442970Phase 25 trials
Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus
- SHR-1139Phase 25 trials
Guangdong Hengrui Pharmaceutical Co., Ltd · Moderate to Severe Plaque Psoriasis, Palmoplantar Pustulosis of Adults, Pyoderma Gangrenosum
- MORF-057zotemtegrast, LY4268989Phase 24 trials
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) · Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis (UC)
- IPG11406Phase 23 trials
Nanjing Immunophage Biotech Co., Ltd · Lupus Nephritis, Moderately to Severely Active Ulcerative Colitis (UC)
- ABBV-701Phase 22 trials
AbbVie · Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis
- anti-TL1A monoclonal antibodyPhase 22 trials
Biocad · Ulcerative Colitis (UC), Crohn's Disease (CD)
- EltrekibartLY3041658Phase 22 trials
Eli Lilly · Ulcerative Colitis, Ulcerative Colitis Chronic, Hidradenitis Suppurativa
- HSK47388Phase 22 trials
Haisco Pharmaceutical Group Co., Ltd. · Plaque Psoriasis, Ulcerative Colitis (UC)
- LY4395089Phase 22 trials
Eli Lilly · Crohn Disease, Colitis, Ulcerative
- RosnilimabANB030Phase 22 trials
AnaptysBio, Inc. · Rheumatoid Arthritis, Ulcerative Colitis
- SPY001SPY001-001Phase 22 trials
Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis
- SPY002SPY002-091Phase 22 trials
Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis
- SPY003SPY003-207Phase 22 trials
Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis
- TrosunilimabABBV-382Phase 22 trials
AbbVie · Crohn's Disease, Ulcerative Colitis
- ABBV-668Phase 21 trial
AbbVie · Ulcerative Colitis
- ALTB-268Phase 21 trial
AltruBio Inc. · Ulcerative Colitis
- ATH-063Phase 21 trial
Athos Therapeutics Inc · Ulcerative Colitis, Inflammatory Bowel Diseases, Autoimmune Diseases
- BGP-014Phase 21 trial
BioGaia Pharma AB · Ulcerative Colitis
- BI 3032950Phase 21 trial
Boehringer Ingelheim · Ulcerative Colitis
- GarutadustatISM5411Phase 21 trial
InSilico Medicine Hong Kong Limited · Ulcerative Colitis
- HRS-7085Phase 21 trial
Shandong Suncadia Medicine Co., Ltd. · Adult Patients With Moderately to Severely Active Ulcerative Colitis
- INT-210Phase 21 trial
Innatus Therapeutics (Shanghai) Co., Ltd. · Ulcerative Colitis (UC)
- MB-001Phase 21 trial
Mage Biologics · Ulcerative Colitis (UC)
- MGT-006Phase 21 trial
Metagen Therapeutics, Inc. · Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
- MK-8690PRA052Phase 21 trial
Merck & Co. · Colitis Ulcerative, Ulcerative Colitis
- MT-201Phase 21 trial
Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease
- MT-501Phase 21 trial
Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease
- OD-07656Phase 21 trial
Odyssey Therapeutics, Inc. · Ulcerative Colitis (UC), UC - Ulcerative Colitis
- PALI-2108Phase 21 trial
Palisade Bio · Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
- PL8177Active study medicationPhase 21 trial
Palatin Technologies, Inc · Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative
- PTT-621Phase 21 trial
Pyrotech Therapeutics, Inc. · Ulcerative Colitis (UC)
- RO7837195Phase 21 trial
Roche (Genentech) · Ulcerative Colitis
- SAR443122Phase 21 trial
Sanofi · Colitis Ulcerative
- XmAb942Phase 21 trial
Xencor, Inc. · Ulcerative Colitis (UC)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.